UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
 
FORM 6-K 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of July 2024
 
Commission File Number: 001-34541
 
GLOBAL CORD BLOOD CORPORATION
(Translation of registrant’s name into English)
 
48th Floor, Bank of China Tower
1 Garden Road
Central
Hong Kong S.A.R.
(Address of Principal Executive Offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F ⌧  Form 40-F ☐
 
 
 


Introductory Note
 
On September 22, 2022, the Grand Court of the Cayman Islands (the “Court”) issued an order appointing Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited, and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited, as joint provisional liquidators (the “JPLs”) of Global Cord Blood Corporation (the “Company”) pursuant to Section 104(2) of the Companies Act (as amended) of the Cayman Islands.
 
Communications Respecting Summons for Court Approval of JPL Remuneration
 
As previously reported, on May 13, 2024, the JPLs filed a summons (the “Summons”) for court approval of their remuneration for the period September 22, 2022 to September 30, 2023. On May 31, 2024, the Company furnished a Report on Form 6-K to the U.S. Securities and Exchange Commission, which contained a copy of a communication dated May 29, 2024, to the Company’s shareholders with respect to such Summons (which Report was subsequently amended on June 4, 2024).
 
On July 18, 2024, a communication was provided to the Company’s shareholders with updated information with respect to the Summons.  A copy of such communication, including the attachments, is attached hereto as Exhibit 99.1.
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
GLOBAL CORD BLOOD CORPORATION
 
 
 
 
By:
   /s/ John Royle
 
Name: 
John Royle
 
Title:
Joint Provisional Liquidator by Order of the Grand Court of the Cayman Islands
 
Dated: July 19, 2024
 
 

 

Exhibit 99.1

Commercial in Confidence
 


 
 
To: All Shareholders


18 July 2024
 
Dear Shareholders,

Grant Thornton Specialist Services (Cayman) Limited
2nd floor Century Yard,
Cricket Square,
PO Box 1044,
Grand Cayman, KY1-1102
Cayman Islands

T +1 (345) 949 8588
F +1 (345) 949 7120
Global Cord Blood Corporation (In Provisional Liquidation) (the “Company”)
Cause No: FSD 106 of 2022 (IKJ)
Cayman Islands company number: 227732
 

On 22 September 2022, the Grand Court of the Cayman Islands (the “Court”) issued an order (the “Court Order”) appointing Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited, and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited, as Joint Provisional Liquidators (the “JPLs”) of the Company pursuant to Section 104(2) of the Companies Act (2023 Revision) of the Cayman Islands (the “Companies Act”).
 
As previously advised the JPLs called an extraordinary general meeting (“EGM”) of the Company’s contributories to be convened on 16 April 2024 for the purpose of considering, and if thought fit, passing ordinary resolutions to (i) approve the JPLs’ proposed terms of remuneration and (ii) approve the JPLs’ remuneration and disbursements for the period 22 September 2022 to 30 September 2023 (“Fee Approval Period”). The JPLs were unable to convene the EGM because it was inquorate and therefore adjourned the EGM to 24 April 2024. The JPLs were unable to convene the adjourned EGM because it was inquorate and therefore dissolved the EGM.
 
On 13 May 2024, the JPLs filed a summons for court approval of their remuneration for the Fee Approval Period pursuant to section 109(2) of the Companies Act and the Insolvency Practitioners’ Regulations (2023 Consolidation) (“Summons”). The Summons has been listed for hearing at 10am on 30 July 2024 (“Hearing Date”). In the lead-up to the Hearing Date, the JPLs filed an amendment to the Summons to seek Court approval of the proposed terms of remuneration and on 17 July 2024, a sealed version of the amended summons was received from the Court Registry (“Amended Summons”). Enclosed is a copy of the Amended Summons.
 
On 18 July 2024 the third affidavit of John Royle (“Royle 3”) was filed with the Court in support of the Amended Summons, please contact the JPLs at gcbcjpls@uk.gt.com should you wish to receive a copy. Please be advised that the JPLs may require documentary evidence of your shareholding in the Company in order for you to receive a copy of the documentation. For the avoidance of any doubt, this notice does not constitute a determination or implied acceptance of that person’s right to be a shareholder, and it is without prejudice to any party’s right to challenge any alleged share issuance by the Company

Yours faithfully
for and on behalf of
Global Cord Blood Corporation (In Provisional Liquidation)

/s/ John Royle

John Royle
Joint Provisional Liquidator of the Company by
Order of the Grand Court of the Cayman Islands

Enclosed:
-            Amended Summons

     
     
     
Chartered Accountants. Grant Thornton Specialist Services (Cayman) Limited is a member firm of Grant Thornton International Ltd (GTIL) and a subsidiary of Grant Thornton UK LLP. GTIL and the member firms are not a worldwide partnership. Services are delivered by the member firms. GTIL and its member firms are not agents of, and do not obligate, one another and are not liable for one another’s acts or omissions. Please see grantthornton.ky for further details. Subject to local regulations.
 
grantthornton.ky

 
Digitally signed by Advance Performance Exponents Inc
Date: 2024.07.17 14:59:13 -05:00
Reason: Apex Certified
Location: Apex

FSD2022-0108
Page 1 of 2
2024-07-17


IN THE GRAND COURT OF THE CAYMAN ISLANDS

FINANCIAL SERVICES DIVISION

CAUSE NO FSD 108 of 2022 (IKJ)

IN THE MATTER OF THE COMPANIES ACT (2023 REVISION)

AND IN THE MATTER OF GLOBAL CORD BLOOD CORPORATION (IN PROVISIONAL LIQUIDATION)



 
AMENDED SUMMONS




LET ALL PARTIES CONCERNED attend before Judge in Chambers, at the Law Courts, George Town, Grand Cayman on                                                     2024 at                am/pm, on the hearing of an application by the Joint Provisional Liquidators of Global Cord Blood Corporation (in Provisional Liquidation) (the “Company”) for orders and directions that:


1.
the Joint Provisional Liquidators’ proposed remuneration agreement be approved;


2.
the Joint Provisional Liquidators’ remuneration of US$10,274,854 incurred during the period 22 September 2022 to 30 September 2023 be approved and paid out of the assets of the Company;


3.
the costs of this application be paid from the liquidation estate as an expense of the provisional liquidation; and


4.
such further and/or other relief as this Honourable Court deems fit.

Dated this 13th day of May 2024



CAMPBELLS LLP


 
THIS AMENDED SUMMONS was filed by Campbells LLP, attorneys for the JPLs, whose address for service is Floor 4, Willow House, Cricket Square, Grand Cayman KY1-9010, Cayman Islands (Ref: LMF/00621-41817)

#3019531v1
3019531-1
FSD2022-0108
Page 1 of 2
2024-07-17


FSD2022-0108
Page 2 of 2
2024-07-17







Attorneys at law for the Company and the Joint Provisional Liquidators

To:
The Registrar of the Financial Services Division
And To:
The Company’s Members
Time Estimate:
The estimated length of the hearing of this Summons is three hours

































2

THIS AMENDED SUMMONS was filed by Campbells, attorneys for the JPLs, whose address for service is Floor 4, Willow House, Cricket Square, Grand Cayman KY1-9010, Cayman Islands (Ref: LMF/00621-41817)

FSD2022-0108
Page 2 of 2
2024-07-17


Global Cord Blood (NYSE:CO)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024 Haga Click aquí para más Gráficas Global Cord Blood.
Global Cord Blood (NYSE:CO)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024 Haga Click aquí para más Gráficas Global Cord Blood.